Analysts’ Weekly Ratings Changes for Inovalon (INOV)

A number of firms have modified their ratings and price targets on shares of Inovalon (NASDAQ: INOV) recently:

  • 7/27/2019 – Inovalon was downgraded by analysts at Zacks Investment Research from a “buy” rating to a “hold” rating. According to Zacks, “Inovalon Holdings, Inc. is a technology company which provides cloud-based data analytics and data-driven intervention platforms for healthcare sector. The company operates through IT and services group. IT operations group manages the process steps from data receipt through to the generation of analytical outputs and services operations group manages the process steps applied to achieve impact through its data-driven intervention platforms. It serves health plans, hospitals, physicians, patients, pharmaceutical companies and researchers. Inovalon Holdings, Inc. is headquartered in Bowie, Maryland. “
  • 7/26/2019 – Inovalon was upgraded by analysts at Zacks Investment Research from a “hold” rating to a “buy” rating. They now have a $17.00 price target on the stock. According to Zacks, “Inovalon Holdings, Inc. is a technology company which provides cloud-based data analytics and data-driven intervention platforms for healthcare sector. The company operates through IT and services group. IT operations group manages the process steps from data receipt through to the generation of analytical outputs and services operations group manages the process steps applied to achieve impact through its data-driven intervention platforms. It serves health plans, hospitals, physicians, patients, pharmaceutical companies and researchers. Inovalon Holdings, Inc. is headquartered in Bowie, Maryland. “
  • 7/19/2019 – Inovalon was downgraded by analysts at Zacks Investment Research from a “buy” rating to a “hold” rating. According to Zacks, “Inovalon Holdings, Inc. is a technology company which provides cloud-based data analytics and data-driven intervention platforms for healthcare sector. The company operates through IT and services group. IT operations group manages the process steps from data receipt through to the generation of analytical outputs and services operations group manages the process steps applied to achieve impact through its data-driven intervention platforms. It serves health plans, hospitals, physicians, patients, pharmaceutical companies and researchers. Inovalon Holdings, Inc. is headquartered in Bowie, Maryland. “
  • 7/18/2019 – Inovalon was upgraded by analysts at Zacks Investment Research from a “hold” rating to a “buy” rating. They now have a $17.00 price target on the stock. According to Zacks, “Inovalon Holdings, Inc. is a technology company which provides cloud-based data analytics and data-driven intervention platforms for healthcare sector. The company operates through IT and services group. IT operations group manages the process steps from data receipt through to the generation of analytical outputs and services operations group manages the process steps applied to achieve impact through its data-driven intervention platforms. It serves health plans, hospitals, physicians, patients, pharmaceutical companies and researchers. Inovalon Holdings, Inc. is headquartered in Bowie, Maryland. “
  • 7/3/2019 – Inovalon was downgraded by analysts at Zacks Investment Research from a “buy” rating to a “hold” rating. According to Zacks, “Inovalon Holdings, Inc. is a technology company which provides cloud-based data analytics and data-driven intervention platforms for healthcare sector. The company operates through IT and services group. IT operations group manages the process steps from data receipt through to the generation of analytical outputs and services operations group manages the process steps applied to achieve impact through its data-driven intervention platforms. It serves health plans, hospitals, physicians, patients, pharmaceutical companies and researchers. Inovalon Holdings, Inc. is headquartered in Bowie, Maryland. “
  • 6/11/2019 – Inovalon was downgraded by analysts at BidaskClub from a “buy” rating to a “hold” rating.

Inovalon stock traded down $0.03 during midday trading on Tuesday, hitting $15.24. 359,161 shares of the stock were exchanged, compared to its average volume of 439,135. The company has a debt-to-equity ratio of 1.46, a current ratio of 1.89 and a quick ratio of 1.89. The firm has a market cap of $2.34 billion, a PE ratio of 84.67, a price-to-earnings-growth ratio of 2.98 and a beta of 0.64. The stock’s 50-day moving average price is $14.63. Inovalon Holdings Inc has a fifty-two week low of $9.19 and a fifty-two week high of $15.65.

Inovalon (NASDAQ:INOV) last posted its quarterly earnings data on Wednesday, May 1st. The technology company reported $0.10 earnings per share for the quarter, beating analysts’ consensus estimates of $0.07 by $0.03. The firm had revenue of $145.50 million for the quarter, compared to analyst estimates of $143.75 million. Inovalon had a negative net margin of 5.28% and a positive return on equity of 6.43%. Inovalon’s quarterly revenue was up 56.8% on a year-over-year basis. During the same period last year, the firm posted ($0.04) EPS. As a group, equities analysts anticipate that Inovalon Holdings Inc will post 0.37 EPS for the current fiscal year.

In other news, CEO Keith R. Dunleavy bought 60,801 shares of the firm’s stock in a transaction that occurred on Friday, May 10th. The stock was acquired at an average price of $13.60 per share, with a total value of $826,893.60. Following the completion of the purchase, the chief executive officer now directly owns 460,801 shares of the company’s stock, valued at approximately $6,266,893.60. The acquisition was disclosed in a filing with the SEC, which is available at this link. Also, CEO Keith R. Dunleavy bought 136,995 shares of the firm’s stock in a transaction that occurred on Tuesday, May 14th. The shares were purchased at an average cost of $13.41 per share, with a total value of $1,837,102.95. Following the purchase, the chief executive officer now directly owns 460,801 shares of the company’s stock, valued at $6,179,341.41. The disclosure for this purchase can be found here. 50.44% of the stock is currently owned by company insiders.

Several large investors have recently added to or reduced their stakes in INOV. FMR LLC boosted its position in shares of Inovalon by 39.2% in the 4th quarter. FMR LLC now owns 6,701,752 shares of the technology company’s stock valued at $95,031,000 after purchasing an additional 1,885,737 shares during the period. Cowen Prime Services LLC boosted its position in shares of Inovalon by 169.4% in the 1st quarter. Cowen Prime Services LLC now owns 611,750 shares of the technology company’s stock valued at $7,604,000 after purchasing an additional 384,650 shares during the period. D. E. Shaw & Co. Inc. boosted its position in shares of Inovalon by 511.6% in the 4th quarter. D. E. Shaw & Co. Inc. now owns 221,147 shares of the technology company’s stock valued at $3,136,000 after purchasing an additional 184,987 shares during the period. First Trust Advisors LP acquired a new position in shares of Inovalon in the 2nd quarter valued at $2,309,000. Finally, BlackRock Inc. boosted its position in shares of Inovalon by 2.4% in the 4th quarter. BlackRock Inc. now owns 5,246,542 shares of the technology company’s stock valued at $74,394,000 after purchasing an additional 124,621 shares during the period. Institutional investors and hedge funds own 32.39% of the company’s stock.

Inovalon Holdings, Inc, a technology company, provides cloud-based platforms empowering data-driven healthcare. It operates the Inovalon ONE Platform, a cloud-based platform that interconnect with the healthcare ecosystem to aggregate and analyze data in real-time, as well as empowers the application in resulting insights.

Featured Story: What are the benefits of momentum investing?

Receive News & Ratings for Inovalon Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inovalon Holdings Inc and related companies with MarketBeat.com's FREE daily email newsletter.